Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
Lancet
    August 2017
  1. SAX PE, Pozniak A, Montes ML, Koenig E, et al
    Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-infer
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32340.
    >> Share

  2. BOFFITO M, Venter F
    The triumph of HIV treatment: another new antiretroviral.
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32297.
    >> Share

  3. GALLANT J, Lazzarin A, Mills A, Orkin C, et al
    Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32299.
    >> Share

  4. GREEN A
    President of Zambia declares HIV testing mandatory.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32295.
    >> Share

  5. THE LANCET
    Losing the fight against HIV in the Philippines.
    Lancet. 2017;390:626.
    >> Share

    July 2017
  6. KARIM SSA, Karim QA, Abimiku A, Bekker LG, et al
    Closing the NIH Fogarty Center threatens US and global health.
    Lancet. 2017;390:451.
    >> Share

  7. HODSON N, Bewley S
    Nelly Mugo and the response to HIV: more than just PrEP advocacy.
    Lancet. 2017;390:358.
    >> Share

  8. GREEN A
    The HIV response in Ukraine: at a crossroads.
    Lancet. 2017;390:347-348.
    >> Share

  9. BEYRER C, Das P, Horton R, Ryan O, et al
    The International AIDS Society-Lancet Commission on the future of the HIV response and global health.
    Lancet. 2017;390:344-345.
    >> Share

  10. GRANICH R, Williams B, Montaner J, Zuniga JM, et al
    90-90-90 and ending AIDS: necessary and feasible.
    Lancet. 2017;390:341-343.
    >> Share

  11. THE LANCET
    The global HIV/AIDS epidemic-progress and challenges.
    Lancet. 2017;390:333.
    >> Share

  12. BOYD MA, Cooper DA
    Long-acting injectable ART: next revolution in HIV?
    Lancet. 2017 Jul 21. pii: S0140-6736(17)31962.
    >> Share

  13. MARGOLIS DA, Gonzalez-Garcia J, Stellbrink HJ, Eron JJ, et al
    Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
    Lancet. 2017 Jul 21. pii: S0140-6736(17)31917.
    >> Share

    March 2017
  14. DANIELS JP
    Venezuela's economic crisis hampers HIV/AIDS treatment.
    Lancet. 2017;389:1088-1089.
    >> Share

  15. HUFFMAN MD, Xavier D, Perel P
    Uses of polypills for cardiovascular disease and evidence to date.
    Lancet. 2017;389:1055-1065.
    >> Share

  16. MENDENHALL E, Kohrt BA, Norris SA, Ndetei D, et al
    Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations.
    Lancet. 2017;389:951-963.
    >> Share

  17. MOHAMMADI D
    Growing older with HIV in the UK.
    Lancet. 2017;389:894-895.
    >> Share

    February 2017
  18. DOWNS JA, Mwakisole AH, Chandika AB, Lugoba S, et al
    Educating religious leaders to promote uptake of male circumcision in Tanzania: a cluster randomised trial.
    Lancet. 2017 Feb 14. pii: S0140-6736(16)32055.
    >> Share

    January 2017
  19. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    >> Share

  20. SHIELS MS, Chernyavskiy P, Anderson WF, Best AF, et al
    Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.
    Lancet. 2017 Jan 25. pii: S0140-6736(17)30187.
    >> Share

  21. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    >> Share

    December 2016
  22. ZHU FC, Wurie AH, Hou LH, Liang Q, et al
    Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32617.
    >> Share

  23. HOOK EW RD
    Syphilis.
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    >> Share

    November 2016
  24. DAS P
    Deborah L Birx: on a mission to end the HIV/AIDS epidemic.
    Lancet. 2016;388:2583.
    >> Share

  25. KIRBY T
    Targeting HIV prevention to young women in Africa.
    Lancet. 2016;388:2579.
    >> Share

  26. KIRBY T
    David Cooper: Australia's fighter against HIV and discrimination.
    Lancet. 2016;388:2469.
    >> Share

  27. YANG YT, Wiley E, Duvivier RJ
    US policy on blood donation by men who have sex with men.
    Lancet. 2016;388:2236-2237.
    >> Share

    October 2016
  28. HONORE JG, Balan JG, Thimothe G, Diallo J, et al
    Instability adversely affects HIV care in Haiti.
    Lancet. 2016;388:1877.
    >> Share

  29. GREEN A
    NIH project focuses on integration of HIV and NCD care.
    Lancet. 2016;388:1869.
    >> Share


  30. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1775-1812.
    >> Share


  31. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1545-1602.
    >> Share


  32. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1459-1544.
    >> Share

  33. QIN Y, Liu F, Tang W, Tang S, et al
    HIV self-testing among high-risk men who have sex with men in China: a cross-sectional study.
    Lancet. 2016;388 Suppl 1:S76.
    >> Share

  34. MAO J, Tang W, Liu C, Wong NS, et al
    Sex tourism among Chinese men who have sex with men: a cross-sectional observational study.
    Lancet. 2016;388 Suppl 1:S75.
    >> Share

  35. TANG S, Tang W, Meyers K, Chan P, et al
    HIV and syphilis among men who have sex with men and transgender individuals in China: a scoping review.
    Lancet. 2016;388 Suppl 1:S74.
    >> Share

  36. TANG W, Mao J, Liu C, Mollan K, et al
    Crowdsourcing health communication about condom use in men who have sex with men in China: a randomised controlled trial.
    Lancet. 2016;388 Suppl 1:S73.
    >> Share

  37. ZHAO P, Tang S, Wang C, Zhang Y, et al
    Recreational drug use among Chinese MSM: results from a national-wide cross-sectional study.
    Lancet. 2016;388 Suppl 1:S69.
    >> Share

  38. TANG W, Mao J, Tang S, Liu C, et al
    Disclosure of sexual orientation in men who have sex with men in China: a cross-sectional survey.
    Lancet. 2016;388 Suppl 1:S68.
    >> Share

  39. SMITH MK, Miller WC, Liu H, Ning C, et al
    Effects of patient load and travel distance on HIV transmission in a cohort of serodiscordant couples in rural China: a longitudinal analysis.
    Lancet. 2016;388 Suppl 1:S65.
    >> Share

  40. WONG NS, Wong KH, Tsang OT, Lee MP, et al
    HIV testing campaigns and treatment interventions for control of epidemic HIV growth among heterosexuals: a mathematical modelling study.
    Lancet. 2016;388 Suppl 1:S49.
    >> Share

  41. KWAN TH, Poon CM, Wong KH, Lee SS, et al
    Effects of HIV diagnosis and enrolment in care on transmission risk of HIV-infected men who have sex with men in Hong Kong: a cross-sectional study.
    Lancet. 2016;388 Suppl 1:S48.
    >> Share

  42. NING C, Smith KM, McCann CD, Hu F, et al
    Mortality and retention in hospital-based and CDC-based antiretroviral service delivery in people living with HIV in the Guangdong Province, China: a prospective cohort study.
    Lancet. 2016;388 Suppl 1:S26.
    >> Share

  43. WONG WC, Jiang S, Ong J, Peng M, et al
    Availability and use of primary care facilities in China: a nationwide representative survey.
    Lancet. 2016;388 Suppl 1:S18.
    >> Share

    September 2016
  44. HADLAND SE, Wood E, Levy S
    How the paediatric workforce can address the opioid crisis.
    Lancet. 2016;388:1260-1.
    >> Share


  45. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015.
    Lancet. 2016 Sep 19. pii: S0140-6736(16)31467.
    >> Share

  46. PAN SW, Li D, Carpiano RM, Spittal PM, et al
    Ethnicity and HIV epidemiology research in China.
    Lancet. 2016;388:1052-3.
    >> Share

  47. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    >> Share

    August 2016
  48. CLARK F
    Gaps remain in Russia's response to HIV/AIDS.
    Lancet. 2016;388:857-8.
    >> Share

  49. PERSAD GC, Emanuel EJ
    The ethics of expanding access to cheaper, less effective treatments.
    Lancet. 2016;388:932-4.
    >> Share

  50. POKU NK
    UN political declaration on HIV and AIDS: where to begin?
    Lancet. 2016;388:743-744.
    >> Share


  51. NHS England: preparing for PrEP.
    Lancet. 2016;388:634.
    >> Share


  52. Reassessing blood donation by men who have sex with men.
    Lancet. 2016;388:534.
    >> Share

  53. KROIDL I, Saathof E, Maganga L, Makunde WH, et al
    Effect of Wuchereria bancrofti infection on HIV incidence in southwest Tanzania: a prospective cohort study.
    Lancet. 2016 Aug 2. pii: S0140-6736(16)31252.
    >> Share

  54. DOWNS JA, Fitzgerald DW
    No more neglect of helminths and HIV.
    Lancet. 2016 Aug 2. pii: S0140-6736(16)31253.
    >> Share

    July 2016
  55. RUBIN R
    US prisons missing opportunities to tackle HIV in inmates.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)31078.
    >> Share

  56. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    >> Share

  57. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    >> Share

  58. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    >> Share

  59. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    >> Share

  60. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    >> Share

  61. SHRAGE L
    African Americans, HIV, and mass incarceration.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30830.
    >> Share

  62. DAS P, Horton R
    On both sides of the prison walls-prisoners and HIV.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30892.
    >> Share

  63. TELISINGHE L, Charalambous S, Topp SM, Herce ME, et al
    HIV and tuberculosis in prisons in sub-Saharan Africa.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30578.
    >> Share

  64. BEYRER C, Kamarulzaman A, McKee M
    Prisoners, prisons, and HIV: time for reform.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30829.
    >> Share

  65. BEYRER C, Baral SD, Collins C, Richardson ET, et al
    The global response to HIV in men who have sex with men.
    Lancet. 2016;388:198-206.
    >> Share

  66. WIKTOR SZ, Hutin YJ
    The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts.
    Lancet. 2016 Jul 6. pii: S0140-6736(16)31018.
    >> Share

    June 2016
  67. WYLIE K, Knudson G, Khan SI, Bonierbale M, et al
    Serving transgender people: clinical care considerations and service delivery models in transgender health.
    Lancet. 2016 Jun 16. pii: S0140-6736(16)00682.
    >> Share

  68. REISNER SL, Poteat T, Keatley J, Cabral M, et al
    Global health burden and needs of transgender populations: a review.
    Lancet. 2016 Jun 16. pii: S0140-6736(16)00684.
    >> Share

  69. GUISE A
    Next generation of comprehensive HIV prevention.
    Lancet. 2016;387:2377-8.
    >> Share

  70. SIDIBE M, Singh PK
    Thailand eliminates mother-to-child transmission of HIV and syphilis.
    Lancet. 2016 Jun 9. pii: S0140-6736(16)30787.
    >> Share

    May 2016
  71. LOMBARD C, Cousens S, Tylleskar T, Van de Perre P, et al
    Trial size, HIV pre-exposure prophylaxis, and breastfeeding - Authors' reply.
    Lancet. 2016;387:2091.
    >> Share

  72. BIRD SM
    Trial size, HIV pre-exposure prophylaxis, and breastfeeding.
    Lancet. 2016;387:2090-1.
    >> Share

  73. SHAPIRO R, Dryden-Peterson S, Powis K, Zash R, et al
    Hidden in plain sight: HIV, antiretrovirals, and stillbirths.
    Lancet. 2016;387:1994-1995.
    >> Share

  74. MOKDAD AH, Forouzanfar MH, Daoud F, Mokdad AA, et al
    Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Lancet. 2016 May 9. pii: S0140-6736(16)00648.
    >> Share

    April 2016
  75. ADAMS P
    Cryptococcal meningitis: a blind spot in curbing AIDS.
    Lancet. 2016;387:1605-6.
    >> Share

  76. SNYDER A
    Willard Cates, Jr.
    Lancet. 2016;387:1506.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016